Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways

Abstract Background Endoplasmic reticulum (ER) stress, promoting lipid metabolism disorders and steatohepatitis, contributes significantly to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Hugan Qingzhi tablets (HQT) has a definite effect in the clinical treatment of NAFLD patients, b...

Full description

Bibliographic Details
Main Authors: Miaoting Yang, Xiaorui Yao, Fan Xia, Shijian Xiang, Waijiao Tang, Benjie Zhou
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Online Access:https://doi.org/10.1186/s12906-024-04336-1
_version_ 1827382421263220736
author Miaoting Yang
Xiaorui Yao
Fan Xia
Shijian Xiang
Waijiao Tang
Benjie Zhou
author_facet Miaoting Yang
Xiaorui Yao
Fan Xia
Shijian Xiang
Waijiao Tang
Benjie Zhou
author_sort Miaoting Yang
collection DOAJ
description Abstract Background Endoplasmic reticulum (ER) stress, promoting lipid metabolism disorders and steatohepatitis, contributes significantly to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Hugan Qingzhi tablets (HQT) has a definite effect in the clinical treatment of NAFLD patients, but its mechanism is still unclear. This study aims to investigate the effects of HQT on ER stress in the liver tissues of NAFLD rats and explore the underlying mechanism. Methods The NAFLD rat model was managed with high-fat diet (HFD) for 12weeks. HQT was administrated in a daily basis to the HFD groups. Biochemical markers, pro-inflammatory cytokines, liver histology were assayed to evaluate HQT effects in HFD-induced NAFLD rats. Furthermore, the expression of ER stress-related signal molecules including glucose regulating protein 78 (GRP78), protein kinase RNA-like endoplasmic reticulum kinase (PERK), p-PERK, eukaryotic translation initiation factor 2α (EIF2α), p-EIF2α, activating transcription factor 4 (ATF4), acetyl-coenzyme A-carboxylase (ACC), activating transcription factor (ATF6), and nuclear factor-kappa B-p65 (NF-κB-p65) were detected by western blot and/or qRT-PCR. Results The histopathological characteristics and biochemical data indicated that HQT exhibited protective effects on HFD-induced NAFLD rats. Furthermore, it caused significant reduction in the expression of ERS markers, such as GRP78, PERK, p-PERK, and ATF6, and subsequently downregulated the expression of EIF2α, p-EIF2α ATF4, ACC, and NF-κB-p65. Conclusions The results suggested that HQT has protective effect against hepatic steatosis and inflammation in NAFLD rats by attenuating ER stress, and the potential mechanism is through inhibition of PERK and ATF6 pathways.
first_indexed 2024-03-08T14:19:23Z
format Article
id doaj.art-a041cfa7af644588afee60bf6564ef6e
institution Directory Open Access Journal
issn 2662-7671
language English
last_indexed 2024-03-08T14:19:23Z
publishDate 2024-01-01
publisher BMC
record_format Article
series BMC Complementary Medicine and Therapies
spelling doaj.art-a041cfa7af644588afee60bf6564ef6e2024-01-14T12:11:44ZengBMCBMC Complementary Medicine and Therapies2662-76712024-01-0124111110.1186/s12906-024-04336-1Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathwaysMiaoting Yang0Xiaorui Yao1Fan Xia2Shijian Xiang3Waijiao Tang4Benjie Zhou5Department of Pharmacy, People’s Hospital of LonghuaDepartment of Pharmacy, Shantou Central HospitalDepartment of Pharmacy, the Seventh Affiliated Hospital, Sun Yat-sen UniversityDepartment of Pharmacy, the Seventh Affiliated Hospital, Sun Yat-sen UniversityZhujiang Hospital, Southern Medical UniversityDepartment of Pharmacy, the Seventh Affiliated Hospital, Sun Yat-sen UniversityAbstract Background Endoplasmic reticulum (ER) stress, promoting lipid metabolism disorders and steatohepatitis, contributes significantly to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Hugan Qingzhi tablets (HQT) has a definite effect in the clinical treatment of NAFLD patients, but its mechanism is still unclear. This study aims to investigate the effects of HQT on ER stress in the liver tissues of NAFLD rats and explore the underlying mechanism. Methods The NAFLD rat model was managed with high-fat diet (HFD) for 12weeks. HQT was administrated in a daily basis to the HFD groups. Biochemical markers, pro-inflammatory cytokines, liver histology were assayed to evaluate HQT effects in HFD-induced NAFLD rats. Furthermore, the expression of ER stress-related signal molecules including glucose regulating protein 78 (GRP78), protein kinase RNA-like endoplasmic reticulum kinase (PERK), p-PERK, eukaryotic translation initiation factor 2α (EIF2α), p-EIF2α, activating transcription factor 4 (ATF4), acetyl-coenzyme A-carboxylase (ACC), activating transcription factor (ATF6), and nuclear factor-kappa B-p65 (NF-κB-p65) were detected by western blot and/or qRT-PCR. Results The histopathological characteristics and biochemical data indicated that HQT exhibited protective effects on HFD-induced NAFLD rats. Furthermore, it caused significant reduction in the expression of ERS markers, such as GRP78, PERK, p-PERK, and ATF6, and subsequently downregulated the expression of EIF2α, p-EIF2α ATF4, ACC, and NF-κB-p65. Conclusions The results suggested that HQT has protective effect against hepatic steatosis and inflammation in NAFLD rats by attenuating ER stress, and the potential mechanism is through inhibition of PERK and ATF6 pathways.https://doi.org/10.1186/s12906-024-04336-1Chinese traditional medicineHugan Qingzhi tablets (HQT)Non-alcoholic fatty liver disease (NAFLD)Hepatoprotective effectEndoplasmic reticulum stress (ERS) pathway
spellingShingle Miaoting Yang
Xiaorui Yao
Fan Xia
Shijian Xiang
Waijiao Tang
Benjie Zhou
Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways
BMC Complementary Medicine and Therapies
Chinese traditional medicine
Hugan Qingzhi tablets (HQT)
Non-alcoholic fatty liver disease (NAFLD)
Hepatoprotective effect
Endoplasmic reticulum stress (ERS) pathway
title Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways
title_full Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways
title_fullStr Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways
title_full_unstemmed Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways
title_short Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways
title_sort hugan qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating perk and atf6 pathways
topic Chinese traditional medicine
Hugan Qingzhi tablets (HQT)
Non-alcoholic fatty liver disease (NAFLD)
Hepatoprotective effect
Endoplasmic reticulum stress (ERS) pathway
url https://doi.org/10.1186/s12906-024-04336-1
work_keys_str_mv AT miaotingyang huganqingzhitabletsattenuatesendoplasmicreticulumstressinnonalcoholicfattyliverdiseaseratsbyregulatingperkandatf6pathways
AT xiaoruiyao huganqingzhitabletsattenuatesendoplasmicreticulumstressinnonalcoholicfattyliverdiseaseratsbyregulatingperkandatf6pathways
AT fanxia huganqingzhitabletsattenuatesendoplasmicreticulumstressinnonalcoholicfattyliverdiseaseratsbyregulatingperkandatf6pathways
AT shijianxiang huganqingzhitabletsattenuatesendoplasmicreticulumstressinnonalcoholicfattyliverdiseaseratsbyregulatingperkandatf6pathways
AT waijiaotang huganqingzhitabletsattenuatesendoplasmicreticulumstressinnonalcoholicfattyliverdiseaseratsbyregulatingperkandatf6pathways
AT benjiezhou huganqingzhitabletsattenuatesendoplasmicreticulumstressinnonalcoholicfattyliverdiseaseratsbyregulatingperkandatf6pathways